TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Volume of neonatal red blood cell transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Intraocular lens (IOL) delivery performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difference between target refraction and postoperative subjective refraction (spherical equivalent)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Pain Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of successful follow-up
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change From Baseline in Treatment Satisfaction Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in postoperative pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Raymond Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Subjects Achieving Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Interleukin-6 (IL-6) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Grafted Area That is Viable at Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in HRSD-24 Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive adverse effects as indexed by the Autobiographical Memory Test (AMT)
Endpoint domain: Adverse events/effects
Primary endpoint: Requirement for Morphine Post-surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Control of hyperglycemia (HbA1c <6.5% + FG<126mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Amount of IV sedation needed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of Brain derived neurotrophic factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total physician time spent on the encounter
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Patients With Richmond Agitation-Sedation Scale (RASS) Scores in Deep Sedation Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Whose Best Response is a Complete Response (CR) or Partial Response (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central insulin sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: hazard ratio of severe toxicity, grade 3-4
Endpoint domain: Adverse events/effects
Primary endpoint: Electroencephalography (Hz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improved mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity of CT reconstruction for axillary lymph node status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Specificity of CT reconstruction for axillary lymph node status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Positive-predictive value (PPV) of CT reconstruction for axillary lymph node status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Negative-predictive value (NPV) of CT reconstruction for axillary lymph node status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: degree of uncertainty about admission to the hospital
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decision making ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of conjunctival samples tested positive for SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Curative resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hedonic Ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intensity Ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive diagnosis rate of lung cancer in I stage
Endpoint domain: Mortality/survival
Primary endpoint: change in advanced magnetic resonance imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Opiate- and Cocaine-negative Urine Samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Are Employed
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Residual Motion During Deep Inspiratory Breath-Hold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CTM midpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expression of ERα, ERβ and GPER
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of PSA testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of documented PSA discussions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Neonatal behavioral assessment scale (NBAS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neurodevelopmental Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nuclear factor kappa B (NFkappaB) activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The anti-tumoural immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FFMI (fat free mass index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SMI (skeletal muscle mass index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment (upper limb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: anti-FIIa activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Subject Reported Overall Vision Quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Monocular Amplitude of Accommodation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Snoring Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidents of treatment-emergent adverse events (TEAEs) during Part A
Endpoint domain: Adverse events/effects
Primary endpoint: Incidents of treatment-emergent serious adverse events (TESAEs) during Part A
Endpoint domain: Adverse events/effects
Primary endpoint: ≥75% improvement vs Baseline in Eczema Area and Severity Index (EASI75) score during Part B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating tumor cells (CTCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Respiratory deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Arrythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) total at Month 3 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants with Safety Adverse Experiences
Endpoint domain: Adverse events/effects
Primary endpoint: 30-day patient survival
Endpoint domain: Mortality/survival
Primary endpoint: Composite measure of Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Serum Biomarkers of Inflammatory Cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Biomarkers of Oxidative Stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous cough clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: HAM-D total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Heart Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: the functional scale of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Breast 23
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline calcification propensity of serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease IBD flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment modality conversion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prenatal Health Knowledge Change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prenatal Health Attitude Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Behavioral Intentions
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Average Frequency of Spontaneous Bowel Movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in acute haemodynamic response (dp/dt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Autologous or Allogenic Blood Transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Prevention of foot drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Circadian rhythm amplitude of plasma epinephrine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Circadian rhythm amplitude of blood pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circadian rhythm amplitude of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patients' entrance surface dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in left-ventricular ejection fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in end diastolic volume index (EDVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in end systolic volume index (ESVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of fetal macrosomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: incidences of delivery room resuscitation
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Subjects With Total PVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraclass correlation coefficient (ICC) of multi modal evoked potential parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Muscle Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Change in the Number of Polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Executive function - Attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Occurrence of at least one cardiovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with HIV-1 viral load < 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with total or meaningful headache relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superoxide dismutase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Side Branch Compromise
Endpoint domain: Adverse events/effects
Primary endpoint: oxygenation of the forearm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 1-repetition Maximum (RM) Muscle Strength (Leg Press, Paretic Side)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in 1-RM Muscle Strength (Leg Press, Non-Paretic Side)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Assessment of anti-Gal IgG antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Measurement of serum chemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of secondary surgical interventions (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute change in POEM score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrent distressing dreams
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Activity of Anti-FXa and anti-FIIa markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Receipt of additional intervention or follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Tolerance of Risk in Play
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of adverse events or toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Closure of macular holes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of radiological symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cotinine-Validated Abstinence From Smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracompartmental Pressure (ICP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of bloodstream infections
Endpoint domain: Adverse events/effects
Primary endpoint: Magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitude D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MagD/Mag Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SNR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of real colics according to Wessel definition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of migrainous parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Response to erlotinib therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival at 1 year post-transplant
Endpoint domain: Mortality/survival
Primary endpoint: rate of success on the spontaneous breathing trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Success rates of anesthesia residents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continued opioid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Success rate of the surgical technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area under the concentration-time curve (AUC) of unconjugated Rotigotine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration in plasma (Cmax) of unconjugated Rotigotine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC) of total Rotigotine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in age- and sex-specific BMI percentiles and z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Acceptability of Self-Collection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Self-Collection for HPV
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of the study questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Arm blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microcirculation in colon wall and bowel anastomosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopic Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28 days ventilator free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Variation of most bothersome symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Global Rating of Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Surgical Field Grading Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 1 Year Disease-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: plasma level of total homocysteine (tHcy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative Rate of Spontaneous Abortions
Endpoint domain: Mortality/survival
Primary endpoint: Independently climbing stairs ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate ratios for angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate ratios for myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate ratios for heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Maximum Flow Rate (Qmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in objectively measured free-living physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in adherence to muscle-strengthening guidelines
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: numbers of regulatory T lymphocytes (nTregs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in maximal voluntary strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epithelial penetration rate of sodium fluorescein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI synovitis, bone edema and erosions score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: six-minutes walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's Disease Disability Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EDSS (Expanded Disability Status Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 25 foot timed walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Patients with Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Washed RBC Hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: High-density electroencephalography measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Magnetic Resonance Imaging measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increase of diffusing capacity of the lung for carbon monoxide (DLCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FIT Kit uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Weight management referral rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in pre-bronchodilator forced expiratory volume (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Exercise capacity (six-minute walk)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NYHA/WHO functional class
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Engagement in Formal Substance Abuse Treatment at 30 Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Weight (Lbs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Body Mass Index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Waist-hip Ratio (WHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Fasting Total Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes